About Atlas Genetics’
io® system

Our pioneering, flexible diagnostic instrument and disposable cartridge system is designed for decentralised laboratory, point-of–care and other near-patient settings. It provides a fast, easy-to-use and accurate affordable solution to screening for the presence of STIs, where rapid diagnosis is essential for effective treatment and control.

Find out more

Use of Novel Electrochemical Labels in a Highly Sensitive, Multiplex Detection Method for use in a Rapid Point-of-Care Molecular Assay. As presented at ECCMID, May 2009. (Green, M. et al., 2009.)

We have developed and optimised a novel, highly sensitive, electrochemical molecular assay, for the detection of Chlamydia trachomatis. Performance of this assay has been evaluated in terms of speed to result, analytical sensitivity (limit of detection) and specificity, to assess the value of employing this methodology within a clinical setting.

In addition, we have evaluated the use of a range of different electrochemical labels in a multiplex assay for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae together with an internal control DNA sequence, to investigate the possibility of utilising the electrochemical detection methodology to identify multiple targets within a single sample.

The objective of this work was to validate the electrochemical detection technology for use in a point-of-care environment, and to provide a robust panel of tests that can be integrated onto the Atlas Genetics Velox™ rapid point-of-care platform, which is currently under development.

Access the full PDF publication, sign into "the Hub" now - click here

Get access to all the latest industry insight   SIGN-UP TO THE ATLAS GENETICS RESOURCE HUB

Contact us

Atlas Genetics
Derby Court 
Epsom Square 
White Horse Business Park 
Trowbridge, Wiltshire 
BA14 0XG 
United Kingdom 


+44 (0)1225 717930 



Follow us

Hear more about the ways that 
the Atlas Genetics io® can
assist you